Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB

  • N Engl J Med. 2022 Dec 7. doi: 10.1056/NEJMc2214302.
Masaki Imai  1 ,  Mutsumi Ito  1 ,  Maki Kiso  1 ,  Seiya Yamayoshi  1 ,  Ryuta Uraki  1 ,  Shuetsu Fukushi  2 ,  Shinji Watanabe  2 ,  Tadaki Suzuki  2 ,  Ken Maeda  2 ,  Yuko Sakai-Tagawa  1 ,  Kiyoko Iwatsuki-Horimoto  1 ,  Peter J Halfmann  3 ,  Yoshihiro Kawaoka  4
Affiliations
  • 1. University of Tokyo, Tokyo, Japan.
  • 2. National Institute of Infectious Diseases, Tokyo, Japan.
  • 3. University of Wisconsin-Madison, Madison, WI.
  • 4. University of Tokyo, Tokyo, Japan [email protected].
PMID: 36476720 DOI: 10.1056/NEJMc2214302
Products